Other News To Note
Thursday, December 29, 2011
Alnylam Pharmaceuticals Inc., of Cambridge, Mass., reported preclinical data published in Experimental Neurology showing that a small interfering RNA (siRNA) targeting the huntingtin gene resulted in widespread distribution of the siRNA when administered by intrastriatal infusion using convection-enhanced delivery and demonstrated significant silencing of the huntingtin mRNA throughout the striatum.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.